Ashok D. Bandaranayake

1.1k total citations
16 papers, 793 citations indexed

About

Ashok D. Bandaranayake is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Ashok D. Bandaranayake has authored 16 papers receiving a total of 793 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 6 papers in Immunology and 3 papers in Oncology. Recurrent topics in Ashok D. Bandaranayake's work include Antimicrobial Peptides and Activities (3 papers), Immune Cell Function and Interaction (3 papers) and Immunotherapy and Immune Responses (3 papers). Ashok D. Bandaranayake is often cited by papers focused on Antimicrobial Peptides and Activities (3 papers), Immune Cell Function and Interaction (3 papers) and Immunotherapy and Immune Responses (3 papers). Ashok D. Bandaranayake collaborates with scholars based in United States, South Africa and Australia. Ashok D. Bandaranayake's co-authors include Steven C. Almo, Miguel E. Moreno‐García, Karen Sommer, David J. Rawlings, Joel L. Pomerantz, Beichu Guo, Yulia Ovechkina, David J. Rawlings, Roland K. Strong and Colin Correnti and has published in prestigious journals such as Nucleic Acids Research, Nature Communications and SHILAP Revista de lepidopterología.

In The Last Decade

Ashok D. Bandaranayake

16 papers receiving 787 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ashok D. Bandaranayake United States 11 428 317 212 120 91 16 793
Susan Fong United States 15 675 1.6× 270 0.9× 227 1.1× 173 1.4× 84 0.9× 19 1.2k
Rebecca J. Boohaker United States 15 612 1.4× 148 0.5× 129 0.6× 198 1.6× 43 0.5× 34 897
Sandra Carvalho Portugal 17 687 1.6× 376 1.2× 165 0.8× 227 1.9× 81 0.9× 21 1.2k
Antonella Caivano Italy 21 895 2.1× 222 0.7× 431 2.0× 147 1.2× 44 0.5× 44 1.2k
Svetlana Hamm Germany 15 449 1.0× 766 2.4× 174 0.8× 176 1.5× 43 0.5× 25 1.2k
Nirmala Jagadish India 19 622 1.5× 299 0.9× 85 0.4× 171 1.4× 67 0.7× 35 839
Karen Creswell United States 14 428 1.0× 186 0.6× 90 0.4× 150 1.3× 132 1.5× 20 796
Gerold Schwarz Germany 9 429 1.0× 282 0.9× 89 0.4× 156 1.3× 60 0.7× 13 746
You Wang China 15 459 1.1× 119 0.4× 95 0.4× 118 1.0× 54 0.6× 53 702
Haifeng Song China 15 386 0.9× 287 0.9× 159 0.8× 105 0.9× 73 0.8× 32 829

Countries citing papers authored by Ashok D. Bandaranayake

Since Specialization
Citations

This map shows the geographic impact of Ashok D. Bandaranayake's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ashok D. Bandaranayake with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ashok D. Bandaranayake more than expected).

Fields of papers citing papers by Ashok D. Bandaranayake

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ashok D. Bandaranayake. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ashok D. Bandaranayake. The network helps show where Ashok D. Bandaranayake may publish in the future.

Co-authorship network of co-authors of Ashok D. Bandaranayake

This figure shows the co-authorship network connecting the top 25 collaborators of Ashok D. Bandaranayake. A scholar is included among the top collaborators of Ashok D. Bandaranayake based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ashok D. Bandaranayake. Ashok D. Bandaranayake is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Rupert, Peter B., Della Friend, Benjamin G. Hoffstrom, et al.. (2023). Novel mesothelin antibodies enable crystallography of the intact mesothelin ectodomain and engineering of potent, T cell-engaging bispecific therapeutics. SHILAP Revista de lepidopterología. 3. 3 indexed citations
2.
Crook, Zachary R., Emily J. Girard, Mi‐Youn Brusniak, et al.. (2022). Ex silico engineering of cystine-dense peptides yielding a potent bispecific T cell engager. Science Translational Medicine. 14(645). eabn0402–eabn0402. 7 indexed citations
3.
Gopalakrishnapillai, Anilkumar, Colin Correnti, Ashok D. Bandaranayake, et al.. (2021). Immunotherapeutic Targeting of Mesothelin Positive Pediatric AML Using Bispecific T Cell Engaging Antibodies. Cancers. 13(23). 5964–5964. 6 indexed citations
5.
Correnti, Colin, Lindsey Doyle, Carla A. Jaeger-Ruckstuhl, et al.. (2020). Engineering and functionalization of large circular tandem repeat protein nanoparticles. Nature Structural & Molecular Biology. 27(4). 342–350. 14 indexed citations
6.
Price, Jason, et al.. (2020). Circumventing colistin resistance by combining colistin and antimicrobial peptides to kill colistin-resistant and multidrug-resistant Gram-negative bacteria. Journal of Global Antimicrobial Resistance. 22. 706–712. 15 indexed citations
7.
Correnti, Colin, Mesfin Gewe, Christopher Mehlin, et al.. (2018). Screening, large-scale production and structure-based classification of cystine-dense peptides. Nature Structural & Molecular Biology. 25(3). 270–278. 48 indexed citations
8.
Crook, Zachary R., Della Friend, Mi‐Youn Brusniak, et al.. (2017). Mammalian display screening of diverse cystine-dense peptides for difficult to drug targets. Nature Communications. 8(1). 2244–2244. 65 indexed citations
9.
Bandaranayake, Ashok D. & Steven C. Almo. (2013). Recent advances in mammalian protein production. FEBS Letters. 588(2). 253–260. 156 indexed citations
10.
Correnti, Colin, Věra Richardson, Ashok D. Bandaranayake, et al.. (2012). Siderocalin/Lcn2/NGAL/24p3 Does Not Drive Apoptosis Through Gentisic Acid Mediated Iron Withdrawal in Hematopoietic Cell Lines. PLoS ONE. 7(8). e43696–e43696. 40 indexed citations
11.
Bandaranayake, Ashok D., Colin Correnti, Byoung Y. Ryu, et al.. (2011). Daedalus: a robust, turnkey platform for rapid production of decigram quantities of active recombinant proteins in human cell lines using novel lentiviral vectors. Nucleic Acids Research. 39(21). e143–e143. 68 indexed citations
12.
Meyer‐Bahlburg, Almut, Ashok D. Bandaranayake, Sarah F. Andrews, & David J. Rawlings. (2009). Reduced c- myc Expression Levels Limit Follicular Mature B Cell Cycling in Response to TLR Signals. The Journal of Immunology. 182(7). 4065–4075. 39 indexed citations
13.
Moreno‐García, Miguel E., Karen Sommer, Hisaaki Shinohara, et al.. (2009). MAGUK-Controlled Ubiquitination of CARMA1 Modulates Lymphocyte NF-κB Activity. Molecular and Cellular Biology. 30(4). 922–934. 26 indexed citations
14.
Bandaranayake, Ashok D., Almut Meyer‐Bahlburg, Sarah F. Andrews, & David J. Rawlings. (2009). Reduced c-myc expression levels limit follicular mature B cell cycling in response to TLR signals (46.6). The Journal of Immunology. 182(1_Supplement). 46.6–46.6. 3 indexed citations
15.
Moreno‐García, Miguel E., et al.. (2007). Proximal Signals Controlling B-Cell Antigen Receptor (BCR) Mediated NF-κB Activation. Advances in experimental medicine and biology. 584. 89–106. 5 indexed citations
16.
Sommer, Karen, Beichu Guo, Joel L. Pomerantz, et al.. (2005). Phosphorylation of the CARMA1 Linker Controls NF-κB Activation. Immunity. 23(6). 561–574. 276 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026